# Ricard Mesı́a

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/ricard-mes-a/

## Facts

| Field | Value |
| --- | --- |
| Citations | 21,070 |
| Field | Head and Neck Cancer Studies |
| h-index | 45 |
| i10-index | 132 |
| Last Known Institution | Universitat Autònoma de Barcelona |
| OpenAlex ID | https://openalex.org/A5037339388 |
| ORCID iD | https://orcid.org/0000-0002-3785-3563 |
| Works | 324 |

## Researcher papers

- [Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study](https://scholariq.org/papers/pembrolizumab-alone-or-with-chemotherapy-versus-cetuximab-with-chemotherapy-for/)

## Researcher topics

- [Head and Neck Cancer Studies](https://scholariq.org/topics/head-and-neck-cancer-studies/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Cancer Diagnosis and Treatment](https://scholariq.org/topics/cancer-diagnosis-and-treatment/)
- [Oral health in cancer treatment](https://scholariq.org/topics/oral-health-in-cancer-treatment/)

## Researcher university

- [Universitat Autònoma de Barcelona](https://scholariq.org/institutions/universitat-autonoma-de-barcelona/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.